Patient Satisfaction in Stroke Patients (PatZuFrie)
This study has been completed.
Sponsor:
Charite University, Berlin, Germany
Collaborator:
German Federal Ministry of Education and Research
Information provided by:
Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT00994409
First received: October 13, 2009
Last updated: November 30, 2010
Last verified: November 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The objective of this trial is to guarantee a follow-up of all stroke and transient ischemic attack (TIA) patients. With this follow-up assessment long term effects of therapy and prevention measures can be detected and monitored. It is part of quality assurance.
| Condition |
|---|
|
Stroke |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Berliner Schlaganfallregister - Nachbefragung Von Patienten Mit Schlaganfall |
Further study details as provided by Charite University, Berlin, Germany:
Primary Outcome Measures:
- Primary efficacy endpoint: Number of patients who state that they received all the information they want about the causes and nature of their illness. [ Time Frame: September 2010 ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Compliance/adherence with discharge medication Activities of daily living [ Time Frame: September 2010 ] [ Designated as safety issue: No ]
- Re-events [ Time Frame: September 2010 ] [ Designated as safety issue: No ]
- Degree of Disability [ Time Frame: September 2010 ] [ Designated as safety issue: No ]
- Mortality [ Time Frame: September 2010 ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 1200 |
| Study Start Date: | July 2008 |
| Study Completion Date: | November 2010 |
| Primary Completion Date: | July 2010 (Final data collection date for primary outcome measure) |
Primary efficacy endpoint: Number of patients who state that they received all the information they want about the causes and nature of their illness Key secondary endpoint(s): Compliance/adherence with discharge medication. Re-events. Degree of Disability. Activities of daily living. Mortality.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Stroke and TIA patients treated at the Charite with acute stroke or TIA onset less than 7 days
Criteria
Inclusion Criteria:
- all patients eligible
Exclusion Criteria:
- none
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00994409
Locations
| Germany | |
| Dept. Neurology, Charité Campus Benjamin Franklin | |
| Berlin, Germany | |
Sponsors and Collaborators
Charite University, Berlin, Germany
German Federal Ministry of Education and Research
Investigators
| Principal Investigator: | Peter U Heuschmann, Professor | Charite University, Berlin, Germany |
More Information
No publications provided
| Responsible Party: | Christian H Nolte MD, Dept. Neurology, Charite Campus Benjamin Franklin |
| ClinicalTrials.gov Identifier: | NCT00994409 History of Changes |
| Other Study ID Numbers: | CSB-PatZuFrie, EA4/019/08 |
| Study First Received: | October 13, 2009 |
| Last Updated: | November 30, 2010 |
| Health Authority: | Germany: Ethics Commission |
Keywords provided by Charite University, Berlin, Germany:
|
Stroke |
Additional relevant MeSH terms:
|
Stroke Cerebral Infarction Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Vascular Diseases Cardiovascular Diseases Brain Infarction Brain Ischemia |
ClinicalTrials.gov processed this record on May 16, 2013